Jacobs Levy Equity Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,616
Closed -$1.14M 950
2024
Q2
$1.14M Sell
28,616
-166,369
-85% -$6.65M ﹤0.01% 702
2024
Q1
$8.56M Sell
194,985
-13,530
-6% -$594K 0.04% 325
2023
Q4
$12.9M Sell
208,515
-346,335
-62% -$21.4M 0.07% 270
2023
Q3
$25.5M Buy
554,850
+171,642
+45% +$7.89M 0.15% 154
2023
Q2
$22M Buy
383,208
+256,827
+203% +$14.8M 0.13% 185
2023
Q1
$4.74M Sell
126,381
-64,291
-34% -$2.41M 0.03% 412
2022
Q4
$5.34M Buy
190,672
+2,633
+1% +$73.8K 0.04% 380
2022
Q3
$5.28M Buy
188,039
+910
+0.5% +$25.6K 0.04% 383
2022
Q2
$6.51M Buy
187,129
+74,613
+66% +$2.6M 0.05% 366
2022
Q1
$4.04M Sell
112,516
-74,813
-40% -$2.69M 0.03% 469
2021
Q4
$4.36M Sell
187,329
-13,799
-7% -$321K 0.03% 457
2021
Q3
$3.82M Buy
201,128
+11,051
+6% +$210K 0.03% 488
2021
Q2
$3.83M Buy
190,077
+65,847
+53% +$1.33M 0.03% 487
2021
Q1
$2.28M Sell
124,230
-9,886
-7% -$181K 0.02% 572
2020
Q4
$2.7M Sell
134,116
-28,811
-18% -$579K 0.02% 513
2020
Q3
$3.06M Sell
162,927
-10,645
-6% -$200K 0.03% 439
2020
Q2
$3.9M Buy
173,572
+2,306
+1% +$51.8K 0.04% 392
2020
Q1
$2.54M Sell
171,266
-8,339
-5% -$124K 0.03% 429
2019
Q4
$3.47M Buy
179,605
+2,284
+1% +$44.1K 0.03% 440
2019
Q3
$3.52M Buy
177,321
+109,189
+160% +$2.17M 0.04% 398
2019
Q2
$1.44M Sell
68,132
-4,821
-7% -$102K 0.02% 578
2019
Q1
$1.49M Buy
72,953
+37,628
+107% +$769K 0.02% 572
2018
Q4
$703K Hold
35,325
0.01% 674
2018
Q3
$680K Buy
+35,325
New +$680K 0.01% 717